Drug intelligence / Profile preview

hyenanchin

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Hyenanchin is a picrotoxane sesquiterpene neurotoxin and the hydroxy metabolite of tutin (also known as hydroxytutin). It is naturally found in the phloem sap of the New Zealand tutu plant (*Coriaria arborea*) and the South African plant *Hyaenanche globosa*. The compound is a significant food safety concern in New Zealand, where it contaminates honey when honeybees collect honeydew from passionvine hoppers (*Scolypopa australis*) feeding on tutu sap. As a picrotoxin-like molecule, hyenanchin acts as a potent antagonist of GABA-A receptors, leading to central nervous system overstimulation, which can manifest as seizures and other neurological symptoms in cases of toxic honey poisoning. It has been the subject of clinical pharmacokinetic studies (e.g., NCT03826537) to determine human absorption and metabolic rates, aiding in the establishment of regulatory limits for honey contamination.

Other names
hydroxytutin2-hydroxytutinmellitoxin
02

Targets

GABAA (Gamma-aminobutyric acid receptor)

Beyond the preview

Go deeper on hyenanchin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hyenanchin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call